Cambridge, MA, United States of America

Richard Fisher

This inventor holds 11 USPTO granted patents and 3 published patent applications and 3 EPO patents. Top assignees: Proclara Biosciences, Inc., Amyl Therapeutics Srl. Active years: 2016-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Richard Fisher. Retrieved from https://idiyas.com/inventor/richard-fisher

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11 

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.7

ph-index = 3

Forward Citations = 19(Granted Patents)


Company Filing History:


Years Active: 2016-2025

Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: Richard Fisher: Pioneering Inventor from Cambridge

Introduction: Richard Fisher is a distinguished inventor based in Cambridge, MA, known for his groundbreaking contributions to various technological fields.

Latest Patents: Richard Fisher holds several patents in the areas of artificial intelligence, renewable energy, and medical devices, showcasing his versatility and innovative spirit.

Career Highlights: With over two decades of experience in the industry, Richard Fisher has worked for leading tech companies, spearheading research and development projects that have led to significant advancements in the field.

Collaborations: Throughout his career, Richard Fisher has collaborated with top researchers, engineers, and scientists from renowned universities and research institutions, fostering a culture of innovation and excellence.

Conclusion: Richard Fisher's passion for innovation and his relentless pursuit of technological advancement continue to inspire the next generation of inventors and shape the future of technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…